Search

everythinglearnresearchcommunity

for

Search:↓

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

A patient with complete hair loss regrew all her hair using tofacitinib.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Upadacitinib may effectively treat resistant lichen planopilaris.

The new formulation improved the skin absorption of the drug Thiocolchicoside.

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.